Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia:
Year of publication
2022
Authors
Kolonen A; Sinisalo M; Huhtala H; Rimpiläinen J; Rintala H; Sankelo M; Koivunen E; Silvennoinen R; Räty R; Ruutu T; Volin L; Porkka K; Jantunen E; Nousiainen T; Kuittinen T; Penttilä K; Pyörälä M; et al
Organizations and authors
Kuopio University Hospital
Jantunen Esa
Pyörälä Marja
Silvennoinen Raija
Nousiainen Tapio
Kuittinen Taru
Publication type
Publication format
Article
Parent publication type
Journal
Article type
Original article
Audience
ScientificPeer-reviewed
Peer-ReviewedMINEDU's publication type classification code
A1 Journal article (refereed), original researchPublication channel information
Journal/Series
Volume
109
Issue
3
Pages
257-270
ISSN
Publication forum
Publication forum level
1
Open access
Open access in the publisher’s service
Yes
Open access of publication channel
Fully open publication channel
Self-archived
No
Other information
Fields of science
General medicine, internal medicine and other clinical medicine
Internationality of the publisher
International
International co-publication
Yes
Co-publication with a company
No
The publication is included in the Ministry of Education and Culture’s Publication data collection
Yes